智通财经网·2026-01-29 09:54Core Viewpoint - The actual controller of Zhaoyan New Drug (06127), Zhou Zhiwen, announced a share reduction plan, intending to reduce his holdings by up to 14.98 million shares, which represents 20.0466% of his total shares and 1.99873% of the company's total share capital [1] Summary by Sections - Share Reduction Plan: Zhou Zhiwen disclosed a plan to reduce his holdings by a maximum of 14.98 million shares through centralized bidding or block trading on the Shanghai Stock Exchange within three months after the announcement [1] - Execution of the Plan: As of January 29, 2026, Zhou Zhiwen had reduced his holdings by 14.979 million shares using block trading and centralized bidding methods, and he decided to terminate the reduction plan ahead of schedule [1]